3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
8
Completed
3
Terminated
1
Sponsor Class
OTHER
243
INDUSTRY
214
NIH
14
NETWORK
14
OTHER_GOV
4
FED
2
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Stomach Neoplasms
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Cancer
1
Adenocarcinoma
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
UNKNOWN
×
Colorectal Neoplasms
×
Clear all
NCT02346955
2020-08-27
MK-6018-001
KitovPharma
Phase 1
Terminated
27 enrolled